Recent Updates
Recently added Catalysts
ABBV Positive Sentiment Score: 70/100

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

Wednesday, January 7, 2026 1 min read
Key Takeaway: AbbVie will announce its full-year and fourth-quarter 2025 financial results on February 4, 2026. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time. This event will be accessible via AbbVie's Investor Relations website, with an archived edition available later.
Price reaction · baseline $223.93 (2026-01-06 close) · hit pre-market · 3 other ABBV headline(s) in the window, move may be shared
day 0 close · peak
+4.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • AbbVie is set to announce its financial results, indicating ongoing business activity.
  • The earnings call provides transparency and engagement with investors.
  • AbbVie continues to focus on innovative medicines across key therapeutic areas.

Full Press Release Details

NORTH CHICAGO, Ill.,Jan. 7, 2026/PRNewswire/ -- AbbVie (NYSE:ABBV) will announce its full-year and fourth-quarter 2025 financial results on Wednesday, February 4, 2026, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website atinvestors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us atwww.abbvie.com. Follow @abbvie onLinkedIn,Facebook,Instagram,X (formerly Twitter), and YouTube.
Media:Gabby Tarbert(224) 244-0111[email protected] Investors:Liz Shea(847) 935-2211[email protected]

Frequently Asked Questions

When will AbbVie announce its 2025 financial results?

AbbVie will announce its financial results on February 4, 2026.

What time is the AbbVie earnings conference call?

The earnings conference call will be held at 8 a.m. Central time.

Where can I access the AbbVie earnings call?

The call can be accessed through AbbVie's Investor Relations website.

Will there be an archived version of the earnings call?

Yes, an archived edition will be available later on the same day.

Tags: ABBV Viatris Investor Conferences Healthcare AbbVie earnings call financial results 2025 investor relations
Last updated: Jan 7, 2026

Biotech snapshot

Cash runway
$9391M liquidity · $0M/mo burn
Low dilution risk
Lead asset
MGdPhase 3
Metastatic Cancer →

Catalyst track record

+32%
best trade around ABBV's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for ABBV.

See every catalyst's timing & PoA →